News Focus
News Focus
Followers 56
Posts 8449
Boards Moderated 0
Alias Born 05/14/2015

Re: Mutat post# 110764

Wednesday, 07/27/2022 7:54:12 AM

Wednesday, July 27, 2022 7:54:12 AM

Post# of 118616
I wouldn't be surprised there will be disappointment, yet again, when no PR of funding or partnership drops this week or anytime in the near or distant future.

Yesterday's PR is a nothing burger.

Wow! Yet another potential patent! Whoooooopty Doooooo! Break out the bud light and let's celebrate on this historic patent!

If anyone infringed on any of RGBP patents, where does Koos come up with the millions of dollars for legal fees it would cost to protect them?

Yeah, that's a doozy of a problem. It's expensive to protect IP as legal fees mount up fast. Dave knows because of the money he had to pay his lawyer to settle the lawsuit against him where he ended up settling for $800K to Chemdiv for stiffing them what he owed them.

Let's get back to reality and acknowledge that all of konman koo's patents are worth less than one cent a share. This patent adds to that because there is no actual sellable therapy to back up what is covered in the patent. Krusty the Koos, Klown CEO of $RGBP, is once again showing he has a lot of sizzle but can't actually produce the steak.

Btw, the mRNA toxic "vaccine" is a total failure. They don't protect against transmission or getting the virus and it comes with some really bad side effects including death.

Everyone is mesmerized with mRNA but fail to understand how difficult it is to deliver it inside of the sell. Pfizer and Moderna's mechanism is highly flawed and toxic. In fact, they completely lied about their clinical trial data covering up how the serious problems with it.

It will be a miracle if Deadbeat Dave can get the FDA to ever approve any of the therapies he has patents on. We already know of one failure, HemaXellerate.

Sorry, not sorry.

FACTS are stubborn things

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y